GGrantIndex
Sort

85,873 grants matching alzheimers

Cell Recognition And Synapse Formation

$1,980,283
Marshall Warren Nirenberg · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL

CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan

$1,980,078
Scott L Letendre · University Of California, San Diego · R24 · FY2024 · MH

Life-course social adversity, pesticide exposure, and cognitive outcomes among an ongoing cohort of mid-life Latina women in an under served agricultural region

$1,980,073
Jacqueline Marie Torres · University Of California, San Francisco · R01 · FY2021 · AG

Single-cell transcriptomic and epigenomic analysis of brain cell vulnerabilities to tauopathies in early AD impacted brain regions

$1,979,459
Xiangmin Xu · University Of California-Irvine · R01 · FY2025 · AG

Gene Therapy for Alzheimer's Disease

$1,978,769
Salk Institute For Biological Studies · P01 · FY2004 · AG

Epidemiology of Biomarkers of Risk and Progression in LOAD

$1,978,440
Richard Mayeux · Columbia University Health Sciences · R01 · FY2010 · AG

Role of GPR39 in Aging-Related Vascular Cognitive Impairment (VCI)

$1,978,218
Nabil J. Alkayed · Oregon Health & Science University · RF1 · FY2022 · AG

Effects-Related Biomarkers of Environmental Neurotoxic Exposures

$1,977,265
Evan P Gallagher · University Of Washington · P42 · FY2017 · ES

Pathophysiological Signaling in Neurodegenerative Disorders

$1,976,663
Jonathan David Geiger · University Of North Dakota · P20 · FY2010 · RR

CELL AND MOLECULAR PATHOBIOLGY OF ALZHEIMER'S DISEASE

$1,975,994
Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2012 · AG

CELL AND MOLECULAR PATHOBIOLGY OF ALZHEIMER'S DISEASE

$1,975,994
Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2014 · AG

Immunometabolic regulation after CNS injury

$1,975,262
Krishnan M. Dhandapani · Augusta University · RF1 · FY2023 · NS

Studies in Alzheimer's disease and Neurodegenerative Diseases

$1,975,214
Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2018 · AG

Social Reward Processing Across the Lifespan: Identifying Risk Factors for Financial Exploitation

$1,975,001
David Victor Smith · Temple Univ Of The Commonwealth · RF1 · FY2021 · AG

Sex Differences in Central Stress Response and Alzheimer's Disease Neuropathology

$1,975,000
Hongxin Dong · Northwestern University At Chicago · RF1 · FY2017 · AG

BACE1 as a Therapeutic Target for Alzheimer's Disease

$1,975,000
Robert J Vassar · Northwestern University At Chicago · RF1 · FY2019 · AG

The regulation of health and longevity by branched-chain amino acids

$1,973,962
Dudley William Lamming · University Of Wisconsin-Madison · RF1 · FY2023 · AG

Veterinary and Colony Management Core

$1,973,953
Peter L Strick · University Of Pittsburgh At Pittsburgh · U19 · FY2024 · AG

National Social Life, Health, and Aging Project: Rounds 4.2 and 4.4

$1,973,143
Linda J Waite · National Opinion Research Center · R01 · FY2023 · AG

Parkinson's Disease and Dementia

$1,972,807
John Q. Trojanowski · University Of Pennsylvania · P50 · FY2012 · NS

Parkinson's Disease and Dementia

$1,972,754
John Q. Trojanowski · University Of Pennsylvania · P50 · FY2015 · NS

Parkinson's Disease and Dementia

$1,972,717
John Q. Trojanowski · University Of Pennsylvania · P50 · FY2016 · NS

Degenerative and Dementing Diseases of Aging

$1,972,358
Stanley B Prusiner · University Of California, San Francisco · P01 · FY2015 · AG

CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan

$1,971,786
Scott L Letendre · University Of California, San Diego · R24 · FY2023 · MH

Epidemiology of Biomarkers of Risk and Progression in LOAD

$1,971,743
Richard Mayeux · Columbia University Health Sciences · R01 · FY2012 · AG